These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 31039653

  • 1. CHA2DS2-Vasc score and CHA2DS2-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents.
    Zhao SG, Xu JJ, Tao ZH, Jin L, Liu Q, Zheng WY, Jiang LQ, Wang NF.
    J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
    Kurtul A.
    Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the Predictive Value of CHA2DS2-VASc Score for In-Stent Restenosis.
    Yilmaz S, Akboga MK, Aras D, Topaloglu S.
    Angiology; 2018 Jan; 69(1):38-42. PubMed ID: 28345395
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Predictive Value of the CHA2DS2-VASc Score for In-Stent Restenosis Among Patients with Drug-Eluting Stents Implantation.
    Zhao J, Hou L, Zhu N, Huang R, Su K, Lei Y, Li Y.
    Int J Gen Med; 2023 Jan; 16():69-76. PubMed ID: 36636712
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
    Cheng G, Chang FJ, Wang Y, You PH, Chen HC, Han WQ, Wang JW, Zhong NE, Min ZQ.
    Med Sci Monit; 2019 Jan 08; 25():240-247. PubMed ID: 30617247
    [Abstract] [Full Text] [Related]

  • 9. Coronary CT angiography (CCTA) using third-generation dual-source CT for ruling out in-stent restenosis.
    Eckert J, Renczes-Janetzko P, Schmidt M, Magedanz A, Voigtländer T, Schmermund A.
    Clin Res Cardiol; 2019 Apr 08; 108(4):402-410. PubMed ID: 30187179
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M, Pross V, Marx N, Hoffmann R.
    Coron Artery Dis; 2012 Nov 08; 23(7):492-6. PubMed ID: 22990414
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
    Baktashian M, Saffar Soflaei S, Kosari N, Salehi M, Khosravi A, Ahmadinejad M, Moohebati M, Ebrahimi M, Rahmani F, Khameneh-Bagheri R, Ahmadi M, Sadabadi F, Tayefi M, Bazhdanzadeh S, Ferns GA, Hashemi SM, Pasdar A, Ghayour-Mobarhan M.
    Cardiovasc Revasc Med; 2019 Jul 08; 20(7):583-587. PubMed ID: 30232022
    [Abstract] [Full Text] [Related]

  • 15. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
    Li M, Hou J, Gu X, Weng R, Zhong Z, Liu S.
    Eur J Med Res; 2022 Jan 22; 27(1):12. PubMed ID: 35065663
    [Abstract] [Full Text] [Related]

  • 16. [Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation].
    Chen J, Chen Y, Tian F, Han Y, Jing J, Liu J, Wang J, Zhou S.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan 22; 42(1):14-8. PubMed ID: 24680263
    [Abstract] [Full Text] [Related]

  • 17. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
    Taşolar H, Çetin M, Ballı M, Bayramoğlu A, Otlu YÖ, Türkmen S, Aktürk E.
    Anatol J Cardiol; 2016 Oct 22; 16(10):742-748. PubMed ID: 27025198
    [Abstract] [Full Text] [Related]

  • 18. Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis.
    Ünal S, Açar B, Yayla Ç, Balci MM, Ertem A, Kara M, Maden O, Dereağzi ŞF.
    Coron Artery Dis; 2016 Sep 22; 27(6):478-82. PubMed ID: 27187546
    [Abstract] [Full Text] [Related]

  • 19. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C, De Cecco CN, Vliegenthart R, Duguay TM, Stubenrauch AC, Rosenberg RD, Varga-Szemes A, Bayer RR, Yang J, Ebersberger U, Baquet M, Jochheim D, Hoffmann E, Steinberg DH, Chiaramida SA, Schoepf UJ.
    J Cardiovasc Comput Tomogr; 2016 Sep 22; 10(5):377-83. PubMed ID: 27431607
    [Abstract] [Full Text] [Related]

  • 20. Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score.
    Cetin M, Cakici M, Zencir C, Tasolar H, Baysal E, Balli M, Akturk E.
    Am J Cardiol; 2014 Mar 15; 113(6):950-6. PubMed ID: 24444782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.